Innere Medizin up2date, Table of Contents Innere Medizin up2date 2014; 02(02): 131-150DOI: 10.1055/s-0034-1377289 Herz, Kreislauf und Gefäße © Georg Thieme Verlag KG Stuttgart · New YorkKathetergestützte Aortenklappenimplantation – TAVI 2014Update TAVI 2014 Anja Gutmann , Paul Biever , Stefan Sorg , Friedhelm Beyersdorf , Manfred Zehender , Christoph Bode , Jochen Reinöhl Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Webb JG, Altwegg L, Boone R et al. Transcatheter aortic valve implantation: Impact on clinical and valve-related outcomes. Circulation 2009; 119: 3009-3016 2 Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: The task force on the management of valvular heart disease of the european society of cardiology. Eur Heart J 2007; 28: 230-268 3 Bonow RO, Carabello BA, Kanu C et al. Acc/aha 2006 guidelines for the management of patients with valvular heart disease: A report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): Developed in collaboration with the society of cardiovascular anesthesiologists: Endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation 2006; 114: e84-231 4 Kolh P, Kerzmann A, Lahaye L et al. Cardiac surgery in octogenarians; peri-operative outcome and long-term results. Eur Heart J 2001; 22: 1235-1243 5 Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006; 15: 312-321 6 Iung B, Cachier A, Baron G et al. Decision-making in elderly patients with severe aortic stenosis: Why are so many denied surgery?. Eur Heart J 2005; 26: 2714-2720 7 Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008 8 Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607 9 Baumgartner H. Hemodynamic assessment of aortic stenosis: Are there still lessons to learn?. J Am Coll Cardiol 2006; 47: 138-140 10 Smid M, Ferda J, Baxa J et al. Aortic annulus and ascending aorta: Comparison of preoperative and periooperative measurement in patients with aortic stenosis. Eur J Radiol 2010; 74: 152-155 11 Ng AC, Delgado V, van der Kley F et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging 2010; 3: 94-102 12 Delgado V, Ng AC, Shanks M et al. Transcatheter aortic valve implantation: Role of multimodality cardiac imaging. Expert Rev Cardiovasc Ther 2010; 8: 113-123 13 Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113: 842-850 14 Kaleschke G, Seifarth H, Kerckhoff G et al. Imaging decision-making for transfemoral or transapical approach of transcatheter aortic valve implantation. EuroIntervention 2010; 6 Suppl G: G20-27 15 Masson JB, Kovac J, Schuler G et al. Transcatheter aortic valve implantation: Review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009; 2: 811-820 16 Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation 2006; 114: 591-596 17 Mukherjee C, Walther T, Borger MA et al. Awake transapical aortic valve implantation using thoracic epidural anesthesia. The Annals of thoracic surgery 2009; 88: 992-994 18 Petronio AS, De Carlo M, Bedogni F et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the corevalve revalving system. Circulation. Cardiovascular interventions 2010; 3: 359-366 19 D'Errigo P, Fusco D, Grossi C et al. [observant: Observational study of appropriateness, efficacy and effectiveness of avr-tavi procedures for the treatment of severe symptomatic aortic stenosis. Study protocol]. G Ital Cardiol (Rome) 11: 897-909 20 Fassl J, Seeberger MD, Augoustides JG. Transcatheter aortic valve implantation: Is general anesthesia superior to conscious sedation?. J Cardiothorac Vasc Anesth 2011; 25: 576-577 21 Ree RM, Bowering JB, Schwarz SK. Case series: Anesthesia for retrograde percutaneous aortic valve replacement – experience with the first 40 patients. Can J Anaesth 2008; 55: 761-768 22 Ender J, Borger MA, Scholz M et al. Cardiac surgery fast-track treatment in a postanesthetic care unit: Six-month results of the leipzig fast-track concept. Anesthesiology 2008; 109: 61-66 23 Hantschel D, Fassl J, Scholz M et al. [leipzig fast-track protocol for cardio-anesthesia. Effective, safe and economical]. Anaesthesist 2009; 58: 379-386 24 Bergmann L, Kottenberg E, Heine T et al. [anesthesia with transfemoral and transapical aortic valve implantation. Periinterventional management and hemodynamic observations]. Herz 2009; 34: 381-387 25 Billings FT, Kodali SK, Shanewise JS. Transcatheter aortic valve implantation: Anesthetic considerations. Anesth Analg 2009; 108: 1453-1462 26 Webb JG, Pasupati S, Achtem L et al. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv 2006; 68: 199-204 27 Guinot PG, Depoix JP, Etchegoyen L et al. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: Analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 2010; 24: 752-761 28 Zamorano JL, Badano LP, Bruce C et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011; 32: 2189-2214 29 Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198 30 Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-1695 31 Eltchaninoff H, Prat A, Gilard M et al. Transcatheter aortic valve implantation: Early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur Heart J 2011; 191-197 32 Thomas M, Schymik G, Walther T et al. Thirty-day results of the sapien aortic bioprosthesis european outcome (source) registry: A european registry of transcatheter aortic valve implantation using the edwards sapien valve. Circulation 2010; 122: 62-69 33 Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308 34 Moat NE, Ludman P, de Belder MA et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The UK Tavi (united kingdom transcatheter aortic valve implantation) registry. J Am Coll Cardiol 2011; 58: 2130-2138 35 Cribier A, Eltchaninoff H, Tron C et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703 36 Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763 37 Rodes-Cabau J, Dumont E, De La Rochelliere R et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008; 102: 1240-1246 38 Lefevre T, Kappetein AP, Wolner E et al. One year follow-up of the multi-centre european partner transcatheter heart valve study. Eur Heart J 2011; 32: 148-157 39 Clavel MA, Webb JG, Rodes-Cabau J et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 2010; 122: 1928-1936 40 Clavel MA, Webb JG, Pibarot P et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009; 53: 1883-1891 41 Bauer F, Eltchaninoff H, Tron C et al. Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation 2004; 110: 1473-1476 42 Walther T, Simon P, Dewey T et al. Transapical minimally invasive aortic valve implantation: Multicenter experience. Circulation 2007; 116: I240-245 43 Bagur R, Rodes-Cabau J, Dumont E et al. Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation. Am J Cardiol 2011; 108: 258-264 44 Reynolds MR, Magnuson EA, Lei Y et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011; 124: 1964-1972 45 Goncalves A, Marcos-Alberca P, Almeria C et al. Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation. Int J Cardiol 2013; 117-122 46 Bagur R, Rodes-Cabau J, Dumont E et al. Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation. Am Heart J 2011; 161: 726-734 47 Ussia GP, Mule M, Barbanti M et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009; 30: 1790-1796 48 Gotzmann M, Pljakic A, Bojara W et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J 2011; 162: 238-245 e231 49 Nuis RJ, Van Mieghem NM et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011; 77: 881-889 50 Sinning JM, Ghanem A, Steinhauser H et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3: 1141-1149 51 Wenaweser P, Pilgrim T, Roth N et al. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Ame Heart J 2011; 161: 1114-1124 52 Dewey TM, Brown DL, Herbert MA et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010; 89: 758-767 53 Abdel-Wahab M, Zahn R, Horack M et al. Aortic regurgitation after transcatheter aortic valve implantation: Incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 2011; 97: 899-906 54 Makkar RR, Fontana GP, Jilaihawi H et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366: 1696-1704 55 Gurvitch R, Wood DA, Tay EL et al. Transcatheter aortic valve implantation: Durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010; 122: 1319-1327 56 Rodés-Cabau J, Webb J, Cheung A et al. Long-term outcomes following transcatheter aortic valve implantation: Insights on prognostic factors and valve durability from the canadian multicenter experience. J Am Coll Cardiol 2012; 59: E10-E10 57 Buellesfeld L, Gerckens U, Schuler G et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 2011; 57: 1650-1657 58 Alli OO, Booker JD, Lennon RJ et al. Transcatheter aortic valve implantation: Assessing the learning curve. JACC Cardiovasc Interv 2012; 5: 72-79 59 Nuis RJ, van Mieghem NM, van der Boon RM et al. Effect of experience on results of transcatheter aortic valve implantation using a medtronic corevalve system. Am J Cardiol 2011; 107: 1824-1829 60 Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the valve academic research consortium. Eur Heart J 2011; 32: 205-217 61 Eggebrecht H, Schmermund A, Voigtlander T et al. Risk of stroke after transcatheter aortic valve implantation (tavi): A meta-analysis of 10,037 published patients. EuroIntervention 2012; 8: 129-138 62 Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: A diffusion-weighted magnetic resonance imaging study. Circulation 2010; 121: 870-878 63 Ghanem A, Muller A, Nahle CP et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: A prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010; 55: 1427-1432 64 Rodes-Cabau J, Dumont E, Boone RH et al. Cerebral embolism following transcatheter aortic valve implantation: Comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011; 57: 18-28 65 Szeto WY, Augoustides JG, Desai ND et al. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg 2011; 26: 348-354 66 Nuis RJ, Piazza N, Van Mieghem NM et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 2011; 78: 457-467 67 Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 2010; 3: 1133-1138 68 Ussia GP, Scarabelli M, Mule M et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2011; 108: 1772-1776 69 Hayashida K, Lefevre T, Chevalier B et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011; 4: 851-858 70 Godino C, Maisano F, Montorfano M et al. Outcomes after transcatheter aortic valve implantation with both edwards-sapien and corevalve devices in a single center: The milan experience. JACC Cardiovasc Interv 2010; 3: 1110-1121 71 Moynagh AM, Scott DJ, Baumbach A et al. Corevalve transcatheter aortic valve implantation via the subclavian artery: Comparison with the transfemoral approach. J Am Coll Cardiol 2011; 57: 634-635 72 Kahlert P, Al-Rashid F, Weber M et al. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz 2009; 34: 398-408 73 Cockburn J, de Belder A, Brooks M et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: Use of the prostar system in 118 cases. Cathetern Cardiovasc Interv 2012; 79: 143-149 74 Van Mieghem NM, Nuis RJ, Piazza N et al. Vascular complications with transcatheter aortic valve implantation using the 18 fr medtronic corevalve system: The rotterdam experience. EuroIntervention 2010; 5: 673-679 75 Saia F, Bordoni B, Marrozzini C et al. Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. Future Cardiol 2011; 7: 321-331 76 Sharp AS, Michev I, Maisano F et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 75: 784-793 77 Godin M, Eltchaninoff H, Furuta A et al. Frequency of conduction disturbances after transcatheter implantation of an edwards sapien aortic valve prosthesis. Am J Cardiol 2010; 106: 707-712 78 Piazza N, Onuma Y, Jesserun E et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008; 1: 310-316 79 Nuis RJ, Van Mieghem NM, Schultz CJ et al. Timing and potential mechanisms of new conduction abnormalities during the implantation of the medtronic corevalve system in patients with aortic stenosis. Eur Heart J 2011; 32: 2067-2074 80 Baan J, Yong ZY, Koch KT et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the corevalve prosthesis. Am Heart J 2010; 159: 497-503 81 Fraccaro C, Buja G, Tarantini G et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011; 107: 747-754 82 Piazza N, Nuis RJ, Tzikas A et al. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 2010; 6: 475-484 83 Grube E, Naber C, Abizaid A et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: A pilot study. JACC Cardiovasc Interv 2011; 4: 751-757 84 John D, Buellesfeld L, Yuecel S et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding corevalve prosthesis. JACC Cardiovasc Interv 2010; 3: 233-243 85 Sherif MA, Abdel-Wahab M et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the medtronic corevalve bioprosthesis. J Am Coll Cardiol 2010; 56: 1623-1629 86 Detaint D, Lepage L, Himbert D et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: Implantation impact of device and annulus discongruence. JACC Cardiovasc I 2009; 2: 821-827 87 Rodes-Cabau J, Dumont E, Doyle D. “Valve-in-valve” for the treatment of paravalvular leaks following transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2009; 74: 1116-1119 88 Ussia GP, Barbanti M, Ramondo A et al. The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis of incidence and 1-year clinical outcomes from the italian corevalve registry. J Am Coll Cardiol 2011; 57: 1062-1068 89 Latib A, Michev I, Laborde JC et al. Post-implantation repositioning of the corevalve percutaneous aortic valve. JACC Cardiovasc Interv 2010; 3: 119-121 90 Thomas M, Schymik G, Walther T et al. One-year outcomes of cohort 1 in the edwards sapien aortic bioprosthesis european outcome (source) registry: The european registry of transcatheter aortic valve implantation using the edwards sapien valve. Circulation 2011; 124: 425-433 91 Gilard M, Eltchaninoff H, Iung B et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715 92 Rodes-Cabau J, Gutierrez M, Bagur R et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 2011; 57: 1988-1999 93 Kapadia SR, Svensson L, Tuzcu EM. Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2009; 73: 966-972 94 Bagur R, Dumont E, Doyle D et al. Coronary ostia stenosis after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3: 253-255 95 Elhmidi Y, Bleiziffer S, Piazza N. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 2011; 161: 735-739 96 Van Linden A, Kempfert J, Rastan AJ et al. Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients. Eur J Cardiothorac Surg 2011; 39: 835-842 97 Bagur R, Webb JG, Nietlispach F et al. Acute kidney injury following transcatheter aortic valve implantation: Predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010; 31: 865-874 98 Taylor J. The time has come for a syntax-like trial for transcatheter aortic valve implantation. Eur Heart J 2011; 32: 128-129 99 Webb JG, Wood DA, Ye J et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 2010; 121: 1848-1857 100 Pasic M, Unbehaun A, Dreysse S. Transapical aortic valve implantation after previous aortic valve replacement: Clinical proof of the “valve-in-valve” concept. J Thorac Cardiovasc Surg 2011; 142: 270-277 101 Kempfert J, Van Linden A, Linke A et al. Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg 2010; 89: 1934-1941 102 Rodés-Cabau J, Webb JG, Cheung A et al. Long-term outcome after transcatheter aortic vlave implantation: Insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 2012; 60: 1864-1875
